Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Datasets
Search by expertise, name or affiliation
Prot# SILCAAT: A Phase III Multicenter Randomized Study of the Biological and Clinical Efficacy of Subcutaneous Recombinant, Human Interleukin-2 in HIV-Infected Patients with Low CD4+ Counts Under Active Antiretroviral Therapy (the "SILCAAT Trial")
Murphy, Robert Leo
(PD/PI)
Medicine, Infectious Diseases Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
2/18/03
→
12/31/08
Funding
University of Minnesota
(SILCAAT)
Chiron Corporation
(SILCAAT)
View all
View less